133 related articles for article (PubMed ID: 38482961)
1. Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes.
Grenier B; Mosnier I; Ferrary E; Nguyen Y; Sterkers O; Kalamarides M; Lahlou G; Daoudi H
Otolaryngol Head Neck Surg; 2024 Jul; 171(1):218-230. PubMed ID: 38482961
[TBL] [Abstract][Full Text] [Related]
2. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
3. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
4. Cochlear implantation after radiosurgery for vestibular schwannoma.
Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
[TBL] [Abstract][Full Text] [Related]
5. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
Roehm PC; Mallen-St Clair J; Jethanamest D; Golfinos JG; Shapiro W; Waltzman S; Roland JT
J Neurosurg; 2011 Oct; 115(4):827-34. PubMed ID: 21761973
[TBL] [Abstract][Full Text] [Related]
6. Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma.
Dornhoffer JR; Haller T; Lohse CM; Driscoll CLW; Neff BA; Saoji A; Link MJ; Carlson ML
Otol Neurotol; 2023 Sep; 44(8):791-797. PubMed ID: 37464449
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
[TBL] [Abstract][Full Text] [Related]
8. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
[TBL] [Abstract][Full Text] [Related]
9. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
10. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
[TBL] [Abstract][Full Text] [Related]
11. Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II.
McClenaghan F; Freeman S; Lloyd S; Stapleton E
Otolaryngol Clin North Am; 2023 Jun; 56(3):587-598. PubMed ID: 37019773
[TBL] [Abstract][Full Text] [Related]
12. Cochlear Implant Outcomes in Neurofibromatosis Type 2: Implications for Management.
Deep NL; Patel EJ; Shapiro WH; Waltzman SB; Jethanamest D; McMenomey SO; Roland JT; Friedmann DR
Otol Neurotol; 2021 Apr; 42(4):540-548. PubMed ID: 33351557
[TBL] [Abstract][Full Text] [Related]
13. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
[TBL] [Abstract][Full Text] [Related]
14. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
Colletti V
Adv Otorhinolaryngol; 2006; 64():167-185. PubMed ID: 16891842
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
16. NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.
Jia H; Nguyen Y; Hochet B; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
Otol Neurotol; 2020 Jan; 41(1):94-99. PubMed ID: 31634276
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma).
Arístegui M; Denia A
Otol Neurotol; 2005 Mar; 26(2):205-10. PubMed ID: 15793406
[TBL] [Abstract][Full Text] [Related]
18. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Cochlear Implantation After Translabyrinthine Vestibular Schwannoma Resection: A Report of 41 Cases.
Sanna M; Piccirillo E; Kihlgren C; Cagliero G; Guidi M; Saleh E
Otol Neurotol; 2021 Oct; 42(9):1414-1421. PubMed ID: 34369443
[TBL] [Abstract][Full Text] [Related]
20. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]